Alvorlige bivirkninger siden markedsføringen inkluderer: – Arterielle tromber såsom myokardieinfarkter eller iskæmi, cerebrovaskulære lidelser og tarm infakt.
Serious adverse reactions reported during the post-marketing period include: – Arterial thrombotic events such as myocardial infarctions or ischaemia, cerebrovascular disorders and bowel infarction.